摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

amino penicillanic acid

中文名称
——
中文别名
——
英文名称
amino penicillanic acid
英文别名
aminopenicillanic acid;(2S,5R)-2-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
amino penicillanic acid化学式
CAS
——
化学式
C8H12N2O3S
mdl
——
分子量
216.261
InChiKey
LTEPSSCJOSLAMO-XRGYYRRGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    109
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • Method for Treating Surfaces with Copolymers
    申请人:Bouloussa Othman
    公开号:US20080226585A1
    公开(公告)日:2008-09-18
    The present invention relates to a method for treating at least a surface of a substrate containing labile hydrogen atoms to confer to it cytotoxic properties or cell-adhesion properties, characterized in that it comprises at least a step consisting of exposing, within a liquid medium, said substrate or a surface thereof with at least a copolymer, said copolymer containing at least a monomer unit of type A including at least a reactive site able to attach to said substrate or said surface by covalent bonds and at least a monomer unit of type B including at least one molecule able to confer antimicrobial, antiviricidal and/or antifungicidal or cell-adhesion properties to said substrate or said surface, said step being carried out in efficient conditions to promote the covalent grafting of said copolymer to said substrate or a surface thereof.
    本发明涉及一种处理含有不稳定氢原子的衬底表面的方法,以赋予其细胞毒性或细胞粘附性能。其特征在于,该方法包括至少一步,其中在液体介质中暴露该衬底或其表面至少一种共聚物,该共聚物包含至少一种A型单体单元,包括至少一种反应位点,能够通过共价键连接到该衬底或该表面,以及至少一种B型单体单元,包括至少一种分子,能够赋予该衬底或该表面抗微生物、抗病毒和/或抗真菌性能或细胞粘附性能,该步骤在有效条件下进行,以促进该共聚物与该衬底或其表面的共价嫁接。
  • Method for Making Ionomers Using Amine Compounds Comprising Salt Functional Groups, Ionomers made by the Method and Sports Equipment Comprising Such Ionomers
    申请人:Kim J. Hyun
    公开号:US20070232756A1
    公开(公告)日:2007-10-04
    Ionomeric reaction products are disclosed that are made by combining a monomer, oligomer or polymer having at least one reactive carboxyl group and/or isocyanate group, or functional group or groups equivalent thereto or derived therefrom, with an amine compound having both an amine and an anionic functional group and a formula [RHN—(R 1 ) m —(X − ) n ] o -M a+ p where R is hydrogen, aliphatic, alicyclic, arylaliphatic or aromatic, R 1 is a linking group that links the amine and salt functional groups and is aliphatic, alicyclic, arylaliphatic or aromatic, X is an anionic group, M is a positively charged species, a is 1-4, m is 0 or greater, n is 1-4, o is 1-4 and p is 0-4, more typically 1-4. An amount of the amine compound is used to react with at least a portion of the reactive functional groups. A method for making a golf ball also is disclosed, as are golf balls comprising disclosed ionomers. At least one component of a golf ball, such as a cover layer, is made comprising disclosed ionomers. The golf ball can have any construction suitable for a golf ball, including multi-layered balls, such as a 3- or 4-piece ball.
    本发明公开了离子聚合物反应产物,其通过将至少具有一个反应性羧基和/或异氰酸酯基或等效的功能基团或由其衍生的单体、低聚物或聚合物与一种同时具有胺基和阴离子功能基团的胺化合物结合而制成,其具有以下化学式[RHN—(R1)m—(X−)n]o-Ma+p,其中R为氢、脂肪、脂环、芳基脂肪或芳香族,R1是连接胺基和盐基团的连接基团,为脂肪、脂环、芳基脂肪或芳香族,X为阴离子基团,M为正电荷物种,a为1-4,m为0或更大,n为1-4,o为1-4,p为0-4,更通常为1-4。使用一定量的胺化合物来与至少部分反应性功能基团反应。本发明还公开了一种制造高尔夫球的方法,以及包括所述离子聚合物的高尔夫球。高尔夫球的至少一个组件,如覆盖层,是由所述离子聚合物制成的。高尔夫球可以具有适合高尔夫球的任何结构,包括多层球,如3或4层球。
  • COMPOSITIONS COMPRISING AN AMINO TRIAZINE AND IONOMER OR IONOMER PRECURSOR
    申请人:Kim Hyun J.
    公开号:US20090270201A1
    公开(公告)日:2009-10-29
    Disclosed embodiments concern using at least one triazine, typically an amine or polyamine triazine (referred to as amino triazines), in combination with at least one ionomer or ionomer precursor to form compositions useful for making sporting equipment, such as golf ball components. The ionomer or ionomer precursor typically includes plural acid functional groups, such as carboxyl or carboxylate groups, that react or form salts with the amino triazine. Specific examples, without limitation, of suitable amino triazines include guanamine, 6-methyl-1,3,5-triazine-2,4-diamine (acetoguanamine), 6-nonyl-1,3,5-triazine-2,4-diamine (nonylguanamine), 6-phenyl-1,3,5-triazine-2,4-diamine (benzoguanamine) and 2,4,6-triamino-triazine (melamine).
    公开的实施例涉及使用至少一种三嗪,通常是胺或多胺三嗪(称为基三嗪),与至少一种离子聚合物或离子聚合物前体结合,形成用于制造运动器材(例如高尔夫球组件)的组合物。离子聚合物或离子聚合物前体通常包括复数酸性官能团,例如羧基或羧酸盐基团,与基三嗪反应或形成盐。适当的基三嗪的具体示例包括、6-甲基-1,3,5-三嗪-2,4-二胺(乙酰)、6-壬基-1,3,5-三嗪-2,4-二胺壬基胍)、6-苯基-1,3,5-三嗪-2,4-二胺苯基胍)和2,4,6-三基-三嗪(三聚氰胺)。
  • Novel penicillanic acid derivatives
    申请人:F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft
    公开号:EP0148283A1
    公开(公告)日:1985-07-17
    @ 6-Amidinopenicillanic acid derivatives wherein one of the nitrogen atoms of the amidino group is part of a heterocyclic ring having on a side chain an unsubstituted heterocyclic ring containing 2 to 3 nitrogen atoms, with formula: wherein n is 0 or 1; is a saturated 5 to 7 membered heterocyclic ring containing the nitrogen atom as the only heteroatom, said ring being unsubstituted or substituted in one or more positions with lower alkyl; is a 5 to 7 membered heterocyclic ring having at most one additional nitrogen atom, from 0 to 2 additional double bonds, and, aside from R, either being unsubstituted or substituted in one or more positions with lower alkyl; R is lower alkyl, nitro, hydrogen,-COOH,-(CH2)y-NHR4;-(CH2)y-OR3 and R3 is hydrogen or lower alkyl, y is an integer from 0 to 4; R, is hydrogen, lower alkyl or an amino-protecting group, (Continuation next page) R5 and R6 are hydrogen or lower alkyl and R7 is lower alkylene, hydrolyzable esters thereof, salts thereof and hydrates thereof, and with formula: wherein n is an integer from 0 to 1; R, is hydrogen or lower alkyl; is a saturated 5 to 7 membered heterocyclic ring containing the nitrogen atom as the only heteroatom, said ring being unsubstituted or substituted in one or more positions with lower alkyl; is a 5 to 7 membered heterocyclic ring containing no additional double bonds or can be additionally aromatic when it is 5 membered, said ring being either unsubstituted or substituted in one or more positions with lower alkyl; and R7 is lower alkylene, hydrolyzable esters thereof, salts thereof and hydrates thereof. These compounds are useful as antibiotics.
    @ 6-脒基青霉烷酸衍生物,其中脒基的一个氮原子是一个杂环的一部分,该杂环的侧链上有一个包含 2 至 3 个氮原子的未取代杂环,其式为 其中 n 为 0 或 1; 是含有氮原子作为唯一杂原子的 5 至 7 个成员的饱和杂环,所述环未经取代或在一个或多个位置被低级烷基取代; R是低级烷基、硝基、氢、-COOH、-(CH2)y-NHR4;-( )y-OR3 和-( )y-OR4。 R3 是氢或低级烷基,y 是 0 至 4 的整数;R, 是氢、低级烷基或基保护基团, (下页接下页) R5 和 R6 是氢或低级烷基,R7 是低级亚烷基,其可解酯、其盐和其合物,并具有 式: 其中 n 是 0 至 1 的整数;R, 是氢或低级烷基; 是含有氮原子作为唯一杂原子的 5 至 7 个成员的饱和杂环,所述环未被取代或在一个或多个位置被低级烷基取代; R7 是低级亚烷基、其可解酯、其盐类和其合物。 这些化合物可用作抗生素。
  • Optically active, ethylenically unsaturated monomers and polymers thereof
    申请人:M & D RESEARCH CO., LTD.
    公开号:EP0281234A1
    公开(公告)日:1988-09-07
    Disclosed are an optically active, ethylenically unsaturated monomer represented by the following structural formula: wherein: A stands for S, SO or SO₂; X and Y each stand for a hydrogen atom or a substituent selected from the group consisting of alkyl groups and acyl groups; Z stands for a substituent selected from the group consisting of alkoxy, alkylamino, hydroxyl and silyloxy groups; and X and Y can be bonded together to form a ring with the nitrogen atom to which they are bonded or X and Y can be a single group bonded to said nitrogen atom through a double bond, with the proviso that at least one of X and Z is an alkenyl equivalent to said group, and polymers of this monomer. One typical instance of the monomer is benzyl 6-acrylaminopenicillanate.
    公开了一种光学活性乙烯基不饱和单体,其结构式如下: 其中A代表S、SO或SO₂;X和Y各自代表一个氢原子或一个选自烷基和酰基的取代基;Z代表一个选自烷氧基、烷基基、羟基和氧基的取代基;X 和 Y 可以键合在一起,与所键合的氮原子形成一个环,或者 X 和 Y 可以是单个基团,通过双键与所述氮原子键合,但条件是 X 和 Z 中至少有一个是与所述基团相当的烯基、 以及这种单体的聚合物。这种单体的一个典型例子是 6-丙烯酰胺青霉烷酸苄酯。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸